A Study of esomeplazole (D961H) in Japanese Paediatric Patients with Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer

Trial Identifier: D961WC00001
Sponsor: AstraZeneca
NCTID:: NCT03553563
Start Date: July 2018
Primary Completion Date: December 2022
Study Completion Date: December 2022
Condition: Digestive & Intestinal - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Japanese Translation

Trial Locations

Country Location
JP Bunkyo-ku, JP, 113-8519
JP Bunkyo-ku, JP, 113-8431
JP Fuji-shi, JP, 417-8567
JP Izumi-shi, JP, 594-1101
JP Kagoshima-shi, JP, 890-8520
JP Kanazawa-shi, JP, 920-8641
JP Kyoto-shi, JP, 602-8566
JP Maebashi-shi, JP, 371-8511
JP Matsumoto-shi, JP, 390-8621
JP Okayama-shi, JP, 701-1192
JP Saitama-shi, JP, 339-8551
JP Sakai-shi, JP, 593-8304
JP Setagaya-ku, JP, 157-8535
JP Shinjuku-ku, JP, 160-0023
JP Takatsuki-shi, JP, 569-8686
JP Yokohama-shi, JP, 232 8555
JP Yokohama-shi, JP, 230-8765